Navigation Links
Fresh bird flu vaccines made in China

The ubiquitous made in China tag, an evidence of the consistent ingenuity displayed by China, has now entered into developing vaccines for bird-flu//. Additionally they have also devised a new technology that will help them detect the disease faster, according to reports released by the Ministry of Agriculture. National Avian Influenza Reference Laboratory has been responsible for developing the vaccines.

The ministry is hopeful of the powerful defensive mechanism embodied in the vaccines when used together, which is capable of fighting the lethal H5N1 strain of bird-flu.

Though the vaccines are yet to go into complete production, the Lab director Chen Hualan said that the vaccines have been very efficient in containing the spread of avian influenza.

Another development in this field is the conception of a novel diagnostic test capable of detecting the H5 virus within minutes, which is absolutely needed to check the spread of infection. According to World Health Organization statistics, a total of 225 human infections leading to 128 deaths globally, have been reported.


'"/>




Page: 1

Related medicine news :

1. Fresh approach to TB treatment
2. Fresh warnings to doctors regarding abortion pill
3. Fresh Cases of Bird-Flu Prepares the Ground for More Chicken Martyrs
4. Fresh Bird Flu Cases Spotted In Southern Russia
5. Pakistan Scared By Fresh Bird Flu Case
6. Fresh Polio Cases Reported In Uttar Pradesh
7. Nothing Can Equate Fresh Vegetables and Fruits
8. Fresh Outbreak Of Bird Flu In Nigeria
9. Foreign Fresher Students Offered Scholarship By Fudan
10. Freshness Dating? Researchers Express Doubts
11. WHO Issues Fresh Guidelines To Long Distance Air Travelers
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Fresh bird flu vaccines made China

(Date:11/20/2008)...y says about 40% returned positive results in revi.... 20 (HealthDay News) -- Colorectal cancer screeni...efully planned to be more effective, say Finnish C...000 people, aged 60 to 64, to determine how sensit...was in identifying unrecognized disease. Half the ...
(Date:11/20/2008).... 20 ReachMD, the first satellite ...y medical professionals, announced,today their ne...erican Medical,Directors Association (AMDA), the ...tending physicians, and others practicing in the l...Crecelius, President of AMDA says, "ReachMD provid...
(Date:11/20/2008)...r 5, the Johns Hopkins Bloomberg School of Public ...ost a half-day symposium to mark the 60th Annivers...The event, "Public Health and Human Rights: The Wo...health and human rights over the last 60 years. ,...High Commissioner for Human Rights will be the key...
(Date:11/20/2008)...and MORRISTOWN, N.J., Nov. 20 /PRNewswire/ Bayer H...he Community Food Bank of New Jersey,(CFBNJ) in r...e for local,pharmaceutical companies to help rest...Photo: http://www.newscom.com/cgi-bin/prnh/200811...Internal Communications, and Anne King,manager, ...
Breaking Medicine News(10 mins):Health News:Colorectal Cancer Screens Detect Unrecognized Disease 2Health News:ReachMD Announces New Strategic Partnership with American Medical Directors Association 2Health News:Bayer HealthCare Donates Hundreds of Food Items to Community Food Bank of New Jersey in Response to Governor's Plea to Help the State's Population in Need 2
...e who put off children until their thirties are ri...a new study. A team of Dutch researchers has found...ves with a history of early menopause is liable to... Led by Dr Jan-Peter de Bruin at the University Me...
... effective utility tool to the field of medicine. ... important decisions about their treatment. The da...e long gone. Patients today expect to participate ...his is difficult, when the clinical evidence gives...
...our genes, and everything to do with your upbringi... as being introverted or extroverted are believed ...researchers presumed the same applied to our sense... identical twins and 56 pairs of fraternal twins, ...
...ain in elderly people was carried out by researche... were investigated to discover the link between dr... show that alcohol is really a double-edged sword....f drinking caused brain shrinkage, which ultimatel...
Other Medicine News:
(Date:11/20/2008)... SAN MARINO, Calif., Nov. 20 Epei... Phase I/II and II studies of Rexin-G in,chemothe...osteosarcoma, as,presented by Dr. Sant P. Chawla,...meetings held in London UK on November 13-15, 2008... i.v. over a period up to 9 months. Analysis of,s...
(Date:11/20/2008)... WASHINGTON, Nov. 20 T...h & Gender Equity: , , WHAT: World AI... , Tuesday, November 25, 2008 , 11:00 a.m. E...trongly encouraged: https://cc.readytalk.com/r/1x...ions outpacing the number of people newly put on t...
(Date:11/20/2008)... CHERRY HILL, N.J., Nov. 20 New J... boil water advisory for its customers in the fol...nion Counties: , , Middlesex County , ,...ddlesex , Piscataway , South Plainfi... , Bound Brook , Bridgewater , ...
(Date:11/20/2008)... , , , , PHILADELPHIA, Nov. 20 /P...K ) today announced that the United States Food an...proval for PROMACTA(R) (eltrombopag) for the treat...immune (idiopathic) thrombocytopenic purpura (ITP)...teroids, immunoglobulins or splenectomy. The appro...
Breaking Medicine Technology:Rexin-G Controls Tumor Growth and Improves Survival in Chemotherapy-Resistant Soft Tissue Sarcoma and Osteosarcoma: Phase I/II & Confirmatory Phase II Studies 2Faith and Civil Society Leaders Call for Truth and Leadership in U.S. HIV Prevention Efforts 2New Jersey American Water Lifts Precautionary Boil Water Advisory For Middlesex, Somerset and Union Counties 2FDA Approves Promacta(R) (Eltrombopag), the First Oral Medication to Increase Platelet Production for People With Serious Blood Disorder 2FDA Approves Promacta(R) (Eltrombopag), the First Oral Medication to Increase Platelet Production for People With Serious Blood Disorder 3FDA Approves Promacta(R) (Eltrombopag), the First Oral Medication to Increase Platelet Production for People With Serious Blood Disorder 4FDA Approves Promacta(R) (Eltrombopag), the First Oral Medication to Increase Platelet Production for People With Serious Blood Disorder 5FDA Approves Promacta(R) (Eltrombopag), the First Oral Medication to Increase Platelet Production for People With Serious Blood Disorder 6FDA Approves Promacta(R) (Eltrombopag), the First Oral Medication to Increase Platelet Production for People With Serious Blood Disorder 7FDA Approves Promacta(R) (Eltrombopag), the First Oral Medication to Increase Platelet Production for People With Serious Blood Disorder 8Warner Chilcott Reports Operating Results for the Quarter Ended September 30 2008 and Updates 2008 Full Year Guidance 29242 1Warner Chilcott Reports Operating Results for the Quarter Ended September 30 2008 and Updates 2008 Full Year Guidance 29242 2Warner Chilcott Reports Operating Results for the Quarter Ended September 30 2008 and Updates 2008 Full Year Guidance 29242 3Warner Chilcott Reports Operating Results for the Quarter Ended September 30 2008 and Updates 2008 Full Year Guidance 29242 4Warner Chilcott Reports Operating Results for the Quarter Ended September 30 2008 and Updates 2008 Full Year Guidance 29242 5Warner Chilcott Reports Operating Results for the Quarter Ended September 30 2008 and Updates 2008 Full Year Guidance 29242 6Warner Chilcott Reports Operating Results for the Quarter Ended September 30 2008 and Updates 2008 Full Year Guidance 29242 7Warner Chilcott Reports Operating Results for the Quarter Ended September 30 2008 and Updates 2008 Full Year Guidance 29242 8Warner Chilcott Reports Operating Results for the Quarter Ended September 30 2008 and Updates 2008 Full Year Guidance 29242 9Warner Chilcott Reports Operating Results for the Quarter Ended September 30 2008 and Updates 2008 Full Year Guidance 29242 10Warner Chilcott Reports Operating Results for the Quarter Ended September 30 2008 and Updates 2008 Full Year Guidance 29242 11Warner Chilcott Reports Operating Results for the Quarter Ended September 30 2008 and Updates 2008 Full Year Guidance 29242 12Warner Chilcott Reports Operating Results for the Quarter Ended September 30 2008 and Updates 2008 Full Year Guidance 29242 13Warner Chilcott Reports Operating Results for the Quarter Ended September 30 2008 and Updates 2008 Full Year Guidance 29242 14Warner Chilcott Reports Operating Results for the Quarter Ended September 30 2008 and Updates 2008 Full Year Guidance 29242 15Warner Chilcott Reports Operating Results for the Quarter Ended September 30 2008 and Updates 2008 Full Year Guidance 29242 16Warner Chilcott Reports Operating Results for the Quarter Ended September 30 2008 and Updates 2008 Full Year Guidance 29242 17Warner Chilcott Reports Operating Results for the Quarter Ended September 30 2008 and Updates 2008 Full Year Guidance 29242 18Cepheid Launches First On Demand Molecular Diagnostic Test for Clostridium Difficile Into European Market 29238 1Cepheid Launches First On Demand Molecular Diagnostic Test for Clostridium Difficile Into European Market 29238 2Cepheid Launches First On Demand Molecular Diagnostic Test for Clostridium Difficile Into European Market 29238 3Cepheid Launches First On Demand Molecular Diagnostic Test for Clostridium Difficile Into European Market 29238 4EntreMeds MKC 1 Meets Primary Efficacy Endpoint in Non Small Cell Lung Cancer Clinical Trial 9021 1EntreMeds MKC 1 Meets Primary Efficacy Endpoint in Non Small Cell Lung Cancer Clinical Trial 9021 2EntreMeds MKC 1 Meets Primary Efficacy Endpoint in Non Small Cell Lung Cancer Clinical Trial 9021 3Andrew Weils Integrative Medicine Program Bestows Honors on Chopra Centers Director of Womens Health 3A Valencia Porter M D receives Integrative Med 29234 1Andrew Weils Integrative Medicine Program Bestows Honors on Chopra Centers Director of Womens Health 3A Valencia Porter M D receives Integrative Med 29234 2
...opharm plc (LSE: PYM) ("Phytopharm" or the "Compan... Cogane(tm) reverses the,changes in the area of th... will be presented by Dr Jonathan Brotchie, an,int...ase at ,The,11th International Congress of Parkins...anbul, Turkey and published in The Movement,Disord...
...tein 90 Inhibitor,Reveal Further Evidence of Safet...GE, Mass. and GAITHERSBURG, Md., June 5, 2007 (PRI...sdaq:INFI) and,MedImmune, Inc. (Nasdaq:MEDI) today...clinical trial of the companies, heat shock,protei...relapsed,refractory gastrointestinal stromal tumo...
Other Medicine Technology:Cogane Data Presented at ‘11th International Congress of,Parkinson’s Disease and Disorders’ 2Cogane Data Presented at ‘11th International Congress of,Parkinson’s Disease and Disorders’ 3Cogane Data Presented at ‘11th International Congress of,Parkinson’s Disease and Disorders’ 4Cogane Data Presented at ‘11th International Congress of,Parkinson’s Disease and Disorders’ 5Infinity and MedImmune Present Updated Phase I Results of IPI-504,in GIST at ASCO Annual Meeting 2Infinity and MedImmune Present Updated Phase I Results of IPI-504,in GIST at ASCO Annual Meeting 3Infinity and MedImmune Present Updated Phase I Results of IPI-504,in GIST at ASCO Annual Meeting 4Infinity and MedImmune Present Updated Phase I Results of IPI-504,in GIST at ASCO Annual Meeting 5Infinity and MedImmune Present Updated Phase I Results of IPI-504,in GIST at ASCO Annual Meeting 6Infinity and MedImmune Present Updated Phase I Results of IPI-504,in GIST at ASCO Annual Meeting 7
Speculum can be used for any type of eye surgery. Arms of speculum lie flat due to joint between blade and arms. Features quick locking mechanism.
Pediatric model. Spring-controlled spread of blades with locking mechanism. Dull finish. Blades: 11 mm.
Fenestrated blades with screw-controlled spread. Dull finish. Blades: 15 mm.
Designed for use with foster enucleation snare (E3670). Package of 12 stainless steel wires. Overall length 5.3 inches.
Medicine Products: